PARP1 expression, activity and ex vivo sensitivity to the PARP inhibitor, talazoparib (BMN 673), in chronic lymphocytic leukaemia.
Herriott A, Tudhope SJ, Junge G, Rodrigues N, Patterson MJ, Woodhouse L, Lunec J, Hunter JE, Mulligan EA, Cole M, Allinson LM, Wallis JP, Marshall S, Wang E, Curtin NJ, Willmore E.
Herriott A, et al. Among authors: patterson mj.
Oncotarget. 2015 Dec 22;6(41):43978-91. doi: 10.18632/oncotarget.6287.
Oncotarget. 2015.
PMID: 26539646
Free PMC article.